Recombinant von Willebrand Factor and Tranexamic Acid for Menstruating Women with von Willebrand Disease Von Willebrand disease is an inherited bleeding disorder affecting about 0.1% of the population. Von Willebrand disease is caused by… September 13, 2023
Concizumab Lowers Rate of Bleeding in Hemophilia Patients with Inhibitors While current guidelines for treating patients with hemophilia A or B recommend intravenous factor VIII or IX concentrates, many patients… September 6, 2023
Limited Data for Plasmapheresis to Treat Post-COVID-19 Condition The COVID-19 pandemic has caused substantial morbidity and mortality. One study estimates that close to 13% of infected individuals experience… August 30, 2023
Intravenous Iron plus Tranexamic Acid for Patients Undergoing Surgery for Hip Fractures Hip fractures are common in older adults, and mortality from hip fractures is approximately 3-5% in the hospital and increases… August 23, 2023
Donor Age, Sex, and Hemoglobin Levels Associated with RBC Transfusion Effectiveness in Very Low Birth Weight Infants About half of very low birth weight (VLBW) infants (<1500 g at birth) require blood transfusions to manage anemia. To… August 16, 2023
SARS-CoV-2 Preferentially Binds Blood Group A Many studies have noted an association between ABO blood group antigens and susceptibility to infection—most commonly that individuals with blood… August 9, 2023
Lymphopenia from Plateletpheresis does not Affect Immune Response Leukoreduction during plateletpheresis is routinely performed to prevent alloimmunization and febrile reactions when platelets are transfused. In 1988, the U.S…. August 2, 2023
Annual U.K. SHOT Report on Serious Hazards of Transfusions The Royal College of Pathologists in the United Kingdom recently published their annual report for 2022 on the Serious Hazards… July 26, 2023
Consensus Definition for Massive Transfusion? Severe bleeding is commonly encountered in surgery, trauma, gastrointestinal hemorrhage and obstetrics and may require massive transfusion (MT). A universal… July 20, 2023
Luspatercept versus Epoetin Alfa for Lower-Risk Myelodysplastic Syndrome Myelodysplastic syndromes (MDS) are caused by a heterogeneous group of hematopoietic stem cell disorders and can progress to acute myeloid… July 12, 2023
